Non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in (morbidly) obese or low body weight patients with atrial fibrillation: a meta-analysis

23 April 2021 (14:00 - 21:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Maxim Grymonprez

University Hospital Ghent, Gent (Belgium)

286 More presentations in this session

Presentation thumbnail

Non-valvular atrial fibrillation recurrence after sinus rhythm restoring at different follow-up periods: phenotype-genotype high-risk groups, considering rs10465885 polymorphism in connexin-40 gene

Doctor T. Mikhalieva (Kyiv, UA)

Abstract Slides

Presentation thumbnail

Atrial fibrillation substrate mapping with decrement evoked potential mapping.

Doctor O. Salvador (Parla, ES)

Abstract Slides

Presentation thumbnail

Atrial tissue characterization by cardiac magnetic resonance and high-density mapping in patients with atrial fibrillation

Miss R. Adelino Recasens (Barcelona, ES)

Abstract Slides

Presentation thumbnail

Proarrhythmic atrial structural and molecular remodeling with advancing age. Implications for post-coronary artery bypass grafting atrial fibrillation occurrence.

Doctor R. SERBAN (Targu Mures, RO)

Abstract Slides

Presentation thumbnail

Find me if you can: lessons learned using the novel cartofinder algorithm in a routine workflow for catheter ablation of atrial fibrillation

Doctor C. Sohns (Bad Oeynhausen, DE)

Abstract Slides

Access the full session

Session thumbnail

ePoster session

The Event

EHRA 2021

23 April 2021 14:00 CET

You may be interested in

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Presentation

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Congress Session

Oral anticoagulation in subclinical atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources